Navigation Links
IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS™
Date:11/3/2010

WEBSTER, Texas, Nov. 3, 2010 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS Transhepatic Biliary System.

SUPERA VERITAS is the next-generation delivery system for IDEV's unique SUPERA® wire interwoven nitinol stent, currently cleared in the U.S. for palliative treatment of biliary strictures produced by malignant neoplasms.  The SUPERA VERITAS system is also approved for use in the ongoing FDA-approved IDE trial in the U.S. for treatment of peripheral arterial disease of the superficial femoral artery (SFA).  The FDA 510(k) clearance notification was dated October 5, 2010.

"Clearance of the SUPERA VERITAS system represents the culmination of a strong effort to respond to customer needs," explained Christopher M. Owens, President and CEO of IDEV.  "The result is an innovative system that we believe provides us with a significant competitive advantage, and may represent a paradigm shift in how patients are treated."

The new device provides easier deployment of the Supera stent compared to earlier systems, eliminating multiple steps previously required for preparation and delivery.  More importantly, the new system allows operators to place the stent more precisely than before.

"I've been deploying the SUPERA stent now for over a year.  The high radial force of the stent is particularly suited for biliary strictures.  The introduction of the SUPERA VERITAS system is a great complement to an outstanding stent," stated Mark Garcia, MD, Chief of Interventional Radiology at Christiana Care Health System in Wilmington, Delaware.

Gino Sedillo, MD, FACC of Bradenton Cardiology Center in Bradenton, Florida, is an investigator in the SFA trial.  He commented, "I've seen the SUPERA VERITAS system demonstrated, and was able to use it myself during a visit to Park Hospital in Leipzig, Germany.  The delivery steps have not only been greatly simplified, but there is also improved reliability and predictability of stent placement.  I look forward to incorporating the new delivery system into the ongoing prospective trial."

Don Jacobs, MD, a vascular surgeon at St. Louis University Hospital in St. Louis, Missouri, was asked to provide feedback on the new delivery system while in Leipzig, Germany and stated, "I was very impressed with the accuracy of the VERITAS system, and appreciated how it improved the ease of delivery of the SUPERA stent.
It represents a truly significant advance and adds significantly to an outstanding product package."

Commercial availability of the SUPERA VERITAS Transhepatic Biliary System is planned for the first quarter of 2011.

About IDEV Technologies, IncorporatedIDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in interventional radiology, vascular surgery and cardiology.  IDEV's worldwide headquarters is located in Webster, Texas and its European headquarters is located in Beuningen, The Netherlands.  Please visit www.idevmd.com.

The SUPERA stent is currently indicated in the U.S. for the palliative treatment of biliary strictures produced by malignant neoplasms and in Europe for the treatment of biliary strictures produced by malignant neoplasms and for peripheral vascular use following failed percutaneous transluminal angioplasty (PTA).Contact:

Donna LucchesiVice President Global MarketingIDEV Technologies, Incorporated(281) 525-2000
'/>"/>

SOURCE IDEV Technologies, Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Patient Safety Technologies Appoints New Chief Financial Officer
2. Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting
3. Frost & Sullivan Award Highlights Hybridyne Technologies Outstanding Technology Innovation
4. CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies
5. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
6. IDEV Technologies Launches Additional Products in Europe
7. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
8. Visonic Technologies Announces the Immediate Availability of its Elpas Door Kit, an All-in-One Starter Kit Packaged With Everything Required to Install a Single-Door Wandering Patient and Resident Protection Solution
9. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
10. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
11. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 17, 2017   Tocagen Inc ., a clinical-stage, cancer-selective gene ... vice president, research and pharmaceutical development at Tocagen, will present at ... held Jan. 17-20 in Miami . ... ... manufacturing for replicating viruses - what to do when and why ...
(Date:1/17/2017)... Jan 17, 2017 Research and Markets has ... Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, ... Forecast to 2021" report to their offering. ... The global active pharmaceutical ingredients ... USD 157.95 Billion in 2016, growing at a CAGR of 6.3% ...
(Date:1/17/2017)... , Jan. 17, 2017 Immune Pharmaceuticals (NASDAQ: ... company, announced today that it will hold a Satellite Symposium ... Acute Leukemias (ISAL) XVI in Munich, Germany ... "Reinforcing the Efficacy of Immunotherapy for the maintenance of ... on Monday February 20 th , 2017 from 12:45 – ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):